Page last updated: 2024-08-22

molybdenum and Bile Duct Obstruction

molybdenum has been researched along with Bile Duct Obstruction in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19901 (25.00)18.7374
1990's1 (25.00)18.2507
2000's1 (25.00)29.6817
2010's1 (25.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, T; McClain, CJ; Song, M; Zhang, J; Zhou, Z1
Arteel, GE; Barve, S; Brewer, GJ; Chen, T; Liu, M; McClain, CJ; Song, M; Song, Z; Zhang, J1
Danks, DM1
Chedid, A; Haux, P; Natelson, S1

Reviews

1 review(s) available for molybdenum and Bile Duct Obstruction

ArticleYear
Copper and liver disease.
    European journal of pediatrics, 1991, Volume: 150, Issue:3

    Topics: Adult; Chelating Agents; Child; Cholestasis; Copper; Hepatolenticular Degeneration; Humans; Infant; Infant, Newborn; Liver Diseases; Molybdenum; Penicillamine; Zinc

1991

Other Studies

3 other study(ies) available for molybdenum and Bile Duct Obstruction

ArticleYear
Copper deficiency exacerbates bile duct ligation-induced liver injury and fibrosis in rats.
    The Journal of pharmacology and experimental therapeutics, 2011, Volume: 339, Issue:1

    Topics: Angiogenesis Inhibitors; Animals; Bile Ducts; Blotting, Western; Body Weight; Cholestasis; Copper; Glutathione; Heme Oxygenase-1; Immunohistochemistry; Iron; Ligation; Liver; Liver Cirrhosis; Lung Injury; Male; Molybdenum; Nutritional Status; Organ Size; Rats; Rats, Sprague-Dawley; Reverse Transcriptase Polymerase Chain Reaction; RNA; S-Adenosylmethionine

2011
Tetrathiomolybdate protects against bile duct ligation-induced cholestatic liver injury and fibrosis.
    The Journal of pharmacology and experimental therapeutics, 2008, Volume: 325, Issue:2

    Topics: Alanine Transaminase; Alkaline Phosphatase; Animals; Aspartate Aminotransferases; Bile Ducts; Bilirubin; Ceruloplasmin; Cholestasis; Copper; Disease Models, Animal; Fibrosis; gamma-Glutamyltransferase; Gene Expression; Ligation; Liver; Male; Mice; Mice, Inbred C57BL; Molecular Sequence Data; Molybdenum; Protective Agents; Transforming Growth Factor beta1; Tumor Necrosis Factor-alpha

2008
Use of thin-layer chromatography on silica gel for serum lipid fractionation and measurement in the routine clinical laboratory.
    Clinical chemistry, 1972, Volume: 18, Issue:4

    Topics: Acute Disease; Adult; Cholestasis; Cholesterol; Chromatography, Thin Layer; Densitometry; Diabetes Mellitus; Esters; Fatty Acids, Nonesterified; Glycerides; Hepatitis; Humans; Hypothyroidism; Lipids; Mathematics; Methods; Molybdenum; Nephrotic Syndrome; Pancreatitis; Phospholipids; Triglycerides

1972